Antirun Nasal Spray (Mometasone Furoate)

Adult use

Allergic rhinitis Adults and adolescents 12 years and older: 2 sprays in each nostril once daily (total daily dose 0.2 mg). When symptoms improve, the maintenance dose can be decreased to 1 spray in each nostril once daily (total daily dose 0.1 mg). If symptoms do not improve, the dose may be increased to a maximum of 4 sprays in each nostril once daily (total daily dose 0.4 mg). Nasal polyps 2 sprays in each nostril once daily.

Child use

Allergic rhinitis Children 2 to 11 years: 1 spray in each nostril once daily (total daily dose 0.1 mg).

This medication should not be used in certain patients. For example, individuals who are allergic to this medicine or any of its components or have experienced hypersensitivity should not use it. Patients with untreated nasal mucosal infections or those who have recently undergone nasal surgery or have injuries in the nasal cavity should also avoid using this medication. It should not be administered to very young children, specifically infants under 2 years of age. Caution is required when used in patients with active or latent tuberculosis, systemic infections, ocular herpes, a history of recurrent nosebleeds, exposure risk to varicella or measles, certain nasal conditions, and women who are pregnant or breastfeeding. Prolonged or high-dose use of this medication could result in systemic side effects. Additionally, serious allergic reactions such as bronchospasm or respiratory distress may occur after nasal administration, and if symptoms appear, the use should be stopped immediately and medical attention sought. When used in children, monitoring for possible growth delays is important, and the minimal effective dosage should always be used. This medication can irritate the nasal mucosa, and prolonged use may lead to local infections or changes in the nasal mucosa, necessitating regular examinations. There may be interactions when used with other medications, especially those that inhibit the CYP3A4 enzyme, which could increase the risk of systemic side effects. Women who are pregnant or breastfeeding should use this medication under a doctor's supervision, considering the potential effects on the fetus or newborn. In cases of overdose, special treatment is often not needed, but excessive use can lead to systemic side effects, such as adrenal insufficiency, necessitating caution. Before use, the container should be shaken well and a test spray should be conducted to ensure uniform spray distribution, taking care not to spray directly into the eyes or septum. Keep this medication out of reach of children, and the effects of this medication on driving or operating machinery are unknown.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, trouble breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain of oral/ocular mucosa, severe skin adverse reactions, difficulty breathing or shortness of breath, asthma attack, respiratory distress with cough and fever, yellowing of the skin or eyes (jaundice), profound lethargy, liver abnormalities (jaundice), sudden and severe headaches, lightning headache.

Mild side effects

Headache, viral infections, pharyngitis, nosebleeds/blood-colored mucus, cough, upper respiratory infections, menstrual pain, musculoskeletal pain, sinusitis, vomiting, joint pain, asthma, bronchitis, chest pain, conjunctivitis, diarrhea, indigestion, earache, cold symptoms, muscle pain, nausea, rhinitis, diarrhea, nasal inflammation, otitis media, wheezing, trauma to the skin, nasal symptoms (irritation, itching, dryness, pain, redness, discomfort, etc.), positive fungal test for the nose.

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain room temperature between 2 degrees and 25 degrees to safely preserve the medication's efficacy.

Appearance

An opaque suspension that is white or nearly white contained in a bottle that sprays a specific amount.

Package unit

140 doses/bottle